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Abstract 
1
 
Flavanols intake has been associated with reduced risk of cancer. In this study, the 
anticarcinogenic effects of the flavanols epicatechin (EC), epicatechin-gallate (ECG) and 
procyanidin B2 (PB2) on Caco-2 and SW480 colon cancer cells were investigated. Catechins 
showed different cytotoxicity depending on the cell line. ECG displayed strong growth inhibitory 
effects against SW480 cells, but was ineffective on Caco-2 cells. In contrast, PB2 did not affect 
Caco-2 cells, whereas promoted cell growth in SW480 cells and EC had no obvious effects on any 
cell line. Exposure of SW480 cells to ECG led to apoptosis as determined by caspase-3 activity, 
imbalance among Bcl-2 anti- and pro-apoptotic protein levels, ERK activation and AKT 
inhibition, whereas PB2 treatment enhanced phospho-AKT and phospho-ERK levels. Incubation 
of Caco-2 cells with ECG increased glutathione levels without affecting the expression of pro- and 
anti-apoptotic Bcl-2 proteins, AKT or ERK. The results suggest that the different cytotoxicity of 
flavanols is caused by their different activity and the degree of differentiation of the colon cancer 
cell line. Thus, ECG induced apoptosis in SW480 cells and contributed to the cytotoxic effect, 
whereas ECG enhanced the antioxidant potential in Caco-2 cells. PB2 activated cell proliferation 
and survival/proliferation pathways in SW480 cells. 
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 Abbreviations: AKT/PKB, protein kinase B; BrDU, 5-bromo-2´-deoxyuridine; CRC, colorectal cancer; 
DCFH, 2′,7′-dichlorofluorescin diacetate; DTT, dithiothreitol; EC, epicatechin; ECG, epicatechin gallate; 
EGCG, epiagallocatechin-3-gallate; ERK, extracellular regulated kinase; FBS, fetal bovine serum; GSH, 
glutathione; GPx, glutathione peroxidase; GR, glutathione reductase; GST, glutathione-S-transferase; 
LDH, lactate dehydrogenase; LY294002, 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one 
hydrochloride; PB2, procyanidin B2; PD98059, 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; 
OPT, o-phthaldehyde; ROS, reactive oxygen species; t-BOOH, tert-butylhydroperoxide. 
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1. Introduction 
There is growing interest in the use of natural products to aid in the maintenance of human health. 
In particular, catechins have been receiving increasing attention. (-)-Epicatechin gallate (ECG), (-
)-epicatechin (EC) and procyanindin B2 (PB2) are catechins abundant in tea and/or cocoa (Babich 
et al., 2005; Lamuela-Raventós et al., 2005). These foodstuffs are widely consumed and have 
increasingly attracted researchers, food manufacturers, as well as consumers due to their health 
benefits, including the prevention of cancer (Ramos, 2007; Vinson et al., 2006). 
Colorectal cancer (CRC) constitutes the most frequent malignancy worldwide (Chan and 
Giovannucci, 2010). It has been described that one-third of human carcinoma might be associated 
with dietary habits, and lifestyle and dietary factors are known to be critical modulators of the 
development of human CRC (Chan and Giovannucci, 2010). Thus, one promising approach to 
reduce the incidence and improve the prognosis of CRC may be chemoprevention through diet. 
Flavanols EC, ECG and PB2 possess a well characterized in vitro antioxidant activity, and recent 
studies have shown that these catechins are effective free radical scavengers and interfere with the 
oxidative/antioxidative potential of hepatic (Coyle et al., 2008; Chen et al., 2002; Granado-Serrano 
et al., 2007, 2009b; Martin et al., 2008) and colonic cells (Rodríguez-Ramiro et al., 2011). 
Induction of antioxidant/detoxifying enzymes as well as glutathione (GSH) levels provide 
significant biological mechanisms for protection against toxic effects of endogenous reactive 
oxygen species (ROS) and exogenous carcinogens and/or their reactive intermediates (Granado-
Serrano et al., 2007, 2009b; Martin et al., 2008, 2010; Rodríguez-Ramiro et al., 2011). 
Alternatively, the removal of preinitiated cells from damaged tissues through cell cycle arrest and 
apoptosis constitutes another possible mechanism in chemoprevention (Babich et al., 2005, 2006; 
Yang et al., 1998). 
Different studies have shown that ECG, and to a much lesser degree EC and procyanidins, are 
potent chemopreventive agents inducing inhibition of cell growth, cell cycle dysregulation, and 
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apoptosis in cells from human oral cavity (Babich et al., 2005), lung and colon (Baek et al., 2004; 
Gossé et al., 2005; Tan et al., 2000; Yang et al., 1998), and in head and neck squamous carcinoma 
cells (Lim et al., 2006). Furthermore, the preventive role of different tea catechins in human 
colorectal cancer is distinct depending on the flavanol (Baek et al., 2004). Accordingly, in HCT-
116 colon cancer cells epigallocatechin-3-gallate (EGCG) and ECG induce apoptosis, but not 
epigallocatechin (EGC) and EC (Baek et al., 2004). Thus, both EGCG and ECG have been 
suggested to play an important role in antitumorigenesis. 
In addition, a differential toxicity of flavonoids in distinct cancer and normal cell lines, as well as 
in cancer cell lines with different growth rate has been reported. Babich et al. (Babich et al., 2005, 
2006) have shown a more pronounced cytotoxic effect for EC, ECG and a theaflavin mixture in 
cancer human oral cavity cells than in their normal counterparts. Similarly, EGCG was the most 
potent catechin compared to EGC, ECG and EC at inhibiting cell growth in prostate cancer cell 
lines, showing that EGCG was particularly effective in the androgen-unresponsive DU145 cells, 
and especially in the androgen responsive LNCaP cells (Paschka et al., 1998). However, contrary 
to EGCG, little input has been directed to evaluate the potential effect on colon cancer cells by EC, 
ECG and PB2. It has been suggested that these compounds might exert beneficial and/or cytotoxic 
actions through their ability to stimulate the antioxidant defense system and their modulation of 
signal cascades (Baek et al., 2004; Granado-Serrano et al., 2007; Lim et al., 2006; Martin et al., 
2008, 2010; Ramos, 2007; Rodríguez-Ramiro et al., 2011), but the exact mechanism of the 
differential effects of EC, ECG and PB2 is still unclear. Therefore, the study of the 
anticarcinogenic activity of flavanols in colonic cells may benefit from the use of two well-defined 
human CRC cell lines with different degrees of growth rate, namely Caco-2 and SW480. Caco-2 is 
a cell line widely used for biochemical and nutritional studies as a differentiated cell culture model 
of human colonocytes since they retain their morphology and most of their function in culture 
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(Sambuy et al., 2005). SW480 cell line is moderately differentiated and invasive (Flatmark et al., 
2004) and it is commonly used in metastasic studies (Yoon et al., 2008). 
These two human colon carcinoma cell lines were used to study the mechanism of the anticancer 
activities of tea and cocoa phenolic components. Thus, cell viability and proliferation were 
assayed for the three flavanols. Later, in view of the results obtained, ROS production and 
intracellular GSH levels as markers for redox status were examined after ECG treatment. Also, the 
mechanisms underlying the biological effects of ECG in Caco-2 and SW480 cells and of PB2 in 
SW480 cells were investigated by evaluating key proteins in survival/proliferation pathways 
[AKT, and extracellular regulated kinase (ERK)], and in apoptotic cell death (caspase-3 and the 
Bcl-2 family members Bcl-xL, Bcl-xS and Bax). 
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2. Materials and methods 
Materials and chemicals 
EC, 2′,7′-dichlorofluorescin diacetate (DCFH), o-phthalaldehyde (OPT), NADH, NADPH, 
LY294002 [2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride], PD98059 [2-(2-
amino-3-methoxyphenyl)-4H-1-benzopyran-4-one], gentamicin, penicillin G and streptomycin 
were purchased from Sigma Chemicals (Madrid, Spain). tert-butylhydroperoxide (t-BOOH) was 
obtained from Panreac Quimica (Madrid, Spain). ECG and PB2 were from Extrasynthese (Genay, 
France). Cell proliferation ELISA 5-bromo-2´-deoxyuridine (BrdU) (colorimetric) assay kit was 
from Roche Diagnostics (Roche Molecular Biochemicals, Barcelona, Spain). GST fluorometric 
activity assay was purchased from Biovision (Deltaclon, Madrid, Spain). Anti-AKT and anti-
phospho-Ser473-AKT, as well as anti-ERK1/2 and anti-phospho-ERK1/2 recognizing 
phosphorylated Thr202/Thy204 of ERK1/2 and anti-β-actin were obtained from Cell Signalling 
Technology (Izasa, Madrid, Spain). Anti-Bclx, anti-Bax and anti-Bad were purchased from Santa 
Cruz Biotechnology (sc-634, sc-526, and sc-943, respectively). Caspase-3 substrate (Ac-DEVD-
AMC) was from BD Pharmingen (Madrid, Spain). Materials and chemicals for electrophoresis and 
the Bradford reagent were obtained from BioRad (Madrid, Spain). Cell culture dishes were from 
Falcon (Cajal, Madrid, Spain) and cell culture medium and fetal bovine serum (FBS) from Lonza 
(Madrid, Spain), respectively. 
 
Cell cultures and flavanol treatments 
Human Caco-2 and SW480 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) F-
12 medium, supplemented with 10% fetal bovine serum (FBS) and 50 mg/L of each antibiotic 
(gentamicin, penicillin and streptomycin). Cells were maintained at 37ºC in a humidified 
atmosphere of 5% CO2. SW480 cells were a gift from Prof. Alberto Muñoz (Instituto de 
Investigaciones Biomedicas “Alberto Sols”, CSIC, Madrid, Spain). 
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Cells were changed to serum-free medium 24 h before the assay in order to avoid the influence of 
the growth factors contained in the FBS on the results. To study the cellular effect of the selected 
flavanols, different concentrations (10-50 M), diluted in serum-free culture medium, were added 
to the cell plates for 24 h. In the experiments with the pharmacological inhibitors, cells were 
preincubated with 50 μM PD98059 (a specific inhibitor of MAPK-ERK) or with 25 μM of 
LY294002 (a specific inhibitor of AKT) for 1 h before and during ECG or PB2 treatments. At the 
end of the incubation period, cell cultures were processed according to the assay (see below). 
 
Cytotoxicity assays 
Cellular damage was evaluated by crystal violet assay (Granado-Serrano et al., 2007) and lactate 
dehydrogenase (LDH) leakage (Granado-Serrano et al., 2009a). For the crystal violet assay, cells 
were seeded (2 x 10
5
 cells per well) in 24-well plates, grown for 20 h with the different treatments 
and then incubated with crystal violet (0.2% in ethanol) for 20 min. Plates were rinsed with water, 
allowed to dry, and 1% sodium dodecylsulfate (SDS) added. The absorbance of each well was 
measured at 570 nm using a microplate reader (Bio-Tek, Winooski, VT, USA). For LDH assay, 
the culture medium and the cells scraped in PBS were collected separately after the different 
treatments. Cells (1.5 x 10
6
 cells) were first sonicated to ensure breaking down the cell membrane 
to release the total amount of LDH, centrifuged (1000g, 15 min) to clear up the cell sample and the 
supernatants collected. To each well of 96-multiwell plates containing the sample (10 L of 
culture medium or cell lysate), 200 L of a mixture comprising 5 mM piruvate, 0.35 mM NADH 
and 84 mM Tris was added and immediately read at 340 nm in a microplate ELISA reader. LDH 
leakage was estimated as the ratio between the LDH activity in the culture medium and that of the 
whole cell content. 
 
Cell proliferation assay (5-bromo-2’-deoxyuridine assay, BrdU) 
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A colorimetric immunoassay (ELISA) was used for the quantification of cell proliferation. This 
method is based on the measurement of BrdU incorporation into genomic DNA during DNA 
synthesis of proliferating cells. Cells were seeded at low density (10
4
 cells per well) in 96-well 
plates, grown 20 h and labelled by the addition of BrdU for 4 h. Then, the anti-BrdU antibody was 
added and the immune complexes were detected by the reaction with the substrate 
tetramethylbenzidine and quantified by measuring the absorbance at 620 nm in a microplate 
ELISA reader. 
 
Determination of reactive oxygen species (ROS) generation 
Cellular ROS generation was quantified by the DCFH assay using a microplate reader (Granado-
Serrano et al., 2007). In brief, 5 M DCFH was added to the wells (2 x 105 cells per well) for 30 
min at 37ºC. Then, cells were washed twice with PBS and serum-free medium or serum-free 
medium with flavanols were added per well. Multiwell plates were immediately measured at the 
fixed times in a fluorescent microplate reader (Bio-Tek, Winooski, VT) at excitation wavelength 
of 485 nm and emission wavelength of 530 nm. After being oxidized by intracellular oxidants, 
DCFH becomes dichlorofluorescein (DCF) and emits fluorescence. By quantifying fluorescence, a 
fair estimation of the overall oxygen species generated under the different conditions was 
obtained. 
 
Determination of reduced glutathione 
Reduced glutathione (GSH) was quantified by the fluorimetric assay of Hissin and Hilf (Hissin 
and Hilf, 1976). The method is based on the reaction of reduced glutathione with OPT at pH 8.0. 
In brief, after the different treatments cells were detached and homogenized by ultrasound with 5% 
trichloroacetic acid and 2 mM EDTA. Following centrifugation of cells at 7000 g for 30 min at 
4ºC, 50 μL of the supernatant were mixed with 1 M NaOH, 0.1 M sodium phosphate buffer and 10 
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μL OPT (10 mg/mL). Fluorescence was measured at excitation wavelength of 340 nm and 
emission wavelength of 460 nm. The results of samples were referred to those of a standard curve 
of GSH. 
 
Determination of glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione-S-
transferase (GST) activity 
For the assay of the GPx and GR activity, treated cells were suspended in PBS and centrifuged at 
300 g for 5 min to pellet cells. Cell pellets were resuspended in 20 mM Tris, 5 mM EDTA and 0.5 
mM mercaptoethanol, sonicated and centrifuged at 3000 g for 15 min. Enzyme activities were 
measured in the supernatants. Determination of GPx activity is based on the oxidation of GSH by 
GPx, using tert-butylhydroperoxide (t-BOOH) as a substrate, coupled to the disappearance of 
NADPH by GR (Alia et al., 2005). GR activity was determined by following the decrease in 
absorbance due to the oxidation of NADPH utilized in the reduction of oxidized glutathione (Alia 
et al., 2005). Analysis of GST was carried out by the commercial kit GST fluorometric activity 
assay. The assay utilizes monochlorobimane (MCB) as an artificial substrate and glutathione to 
determine total GST activity. GST catalyses the MCB-glutathione reactions and the fluorescence 
levels are proportional to the amount of GST present in the reaction medium. A fluorescent 
microplate reader at an excitation wavelength of 380 nm and an emission wavelength of 460 nm 
was used. The activity obtained in mU/mg protein was expressed as percent of control values. 
Protein was measured by using the Bradford reagent. 
 
Fluorometric analysis of caspase-3 activity 
Caspase-3 activity was measured as previously described (Granado-Serrano et al., 2006). Detached 
cells were collected by centrifugation at 2500 g for 5 min at 4ºC. Attached cells were scrapped off 
in PBS and pelleted by centrifugation at 4000 g for 10 min. Cells were pooled and lysed at 4ºC in 
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a buffer containing 5 mM Tris (pH 8), 20 mM EDTA and 0.5% Triton-X100. Later, lysates were 
clarified by centrifugation at 13000 g for 10 min. The reaction mixture contained 20 mM HEPES 
(pH 7), 10% glycerol, 2 mM dithiothreitol (DTT), 30 g protein/condition and 20 M Ac-DEVD-
AMC (N-acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin) as substrate. Enzymatic activity 
was determined by measuring fluorescence at an excitation wavelength of 380 nm and an emission 
wavelength of 440 nm. 
 
Preparation of total cell lysates for Western blotting 
To detect Bclx, Bax, Bad, AKT, phospho-AKT, ERK1/2 and phospho-ERK1/2, cells were lysed at 
4ºC in a buffer containing 25 mM HEPES (pH 7.5), 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 
0.5 mM DTT, 0.1% Triton X-100, 200 mM β-glycerolphosphate, 0.1 mM Na3VO4, 2 μg/mL 
leupeptin and 1 mM phenylmethylsulfonyl fluoride. The supernatants were collected, assayed for 
protein concentration by using the Bio-Rad (Madrid, Spain) protein assay kit according to the 
manufacture´s specifications, aliquoted and stored at -80ºC until used for Western blot analyses. 
 
Western blot analysis 
Equal amounts of proteins (100 μg) were separated by SDS-PAGE and transferred to 
polyvinylidene difluoride filters (Millipore, Madrid, Spain). Membranes were probed with the 
corresponding primary antibody followed by incubation with peroxide-conjugated anti-rabbit 
immunoglobulin (GE Healthcare, Madrid, Spain). Blots were developed with the ECL system (GE 
Healthcare, Madrid, Spain). Normalization of Western blot was ensured by β-actin and band 
quantification was carried out with a scanner (HP Scanjet G2710, HP, Madrid, Spain) and the 
Scion Image software (Scion Corporation, MD, USA). 
 
Statistics 
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All experiments were performed in triplicate or quadruplicate with 2-6 separate samples each (n= 
4-12), as indicated in the legends to figures, and the results were presented as mean ± SD. Prior to 
statistical analysis, data were tested for homogeneity of variances by the test of Levene; for 
multiple comparisons, one-way ANOVA was followed by the Bonferroni test when variances 
were homogeneous or by the Tamhane test when variances were not homogeneous. Different 
letters on top of the bars indicate significantly different results obtained for the corresponding 
analyzed parameter. P<0.05 was considered significant. A SPSS version 17.0 program has been 
used. 
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3. Results 
Effect of flavanols on Caco-2 and SW480 cell viability. 
To determine the potential effects on cell viability of the selected flavanols in both human colon 
cancer cell lines (Caco-2 and SW480), cells were exposed to a range of concentrations (0-50 μM) 
of phenolic compounds for 24 h. 
Treatment of Caco-2 cells for 24 h with any of the three flavanols evoked no changes in cell 
viability, as determined by the crystal violet assay, indicating that the concentrations selected for 
the study did not damage cell integrity during the period of incubation (Figure 1A). Similarly, 
treatment with EC did not induce SW480 cell damage, whereas ECG decreased cell viability at 
concentrations higher than 20 M (Figure 1B). In addition, 20-50 M PB2 caused an increase in 
cell viability after 24 h of treatment as compared to untreated SW480 cells, which could indicate 
an augmented cell proliferation (Figure 1B). 
 
Effect of flavanols on Caco-2 and SW480 cell proliferation. 
To test whether cell proliferation was affected by the selected flavanols, Caco-2 and SW480 cells 
were incubated with the different concentrations for 24 h. 
Treatment of Caco-2 with any of the three flavanols did not affect cell growth, similarly to what 
was observed in SW480 cells after the incubation with EC, indicating no impairment of cell 
proliferative machinery and preservation of a regular cell cycle (Figure 2). On the other hand, in 
SW480 cells 24 h-incubation with PB2 showed an increase in cell proliferation, and ECG 
treatment led to a decrease in cell proliferation (Figure 2B), in agreement with crystal violet results 
(Figure 1). 
Given that ECG was the only flavanol that provoked a potential anticarcinogenic effect by 
inducing cytotoxicity and decreasing cell proliferation in SW480 cells, this was the flavanol 
selected for studying the effects on apoptosis and survival/proliferation pathways. In addition, PB2 
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was chosen to evaluate its effect on key proteins of apoptosis and survival/proliferation pathways 
in SW480 cells since it promoted cell proliferation. 
 
Effect of ECG on Caco-2 and SW480 LDH leakage. 
In view of the different effect observed for ECG on cell viability and proliferation depending on 
the colon cancer cell line, the potential necrotic effect of this flavanol was tested in Caco-2 and 
SW480 cells by measuring the LDH leakage after 24 h of incubation with the different 
concentrations. As shown in Figure 3A, ECG did not induce any cell damage at the concentrations 
assayed (10-50 M) in Caco-2 cells. However, ECG provoked a slight injury in the membrane of 
the SW480 cells at concentrations higher than 20 M (Figure 3B). Thus, it could be suggested that 
Caco-2 cells appeared to be less susceptible to the cytotoxic effect of ECG than SW480 cells after 
24 h of incubation with this flavanol. 
 
Effect of ECG on ROS production and GSH concentration. 
Since flavanols can affect the cellular redox status, we next evaluated ROS generation and reduced 
glutathione (GSH) levels after ECG treatment (24 h) in Caco-2 and SW480 cells. 
ECG evoked a significant reduction of the cellular ROS generation, showing lower levels than 
control cells in both cell lines (Figures 3C and 3D). On the other hand, ECG at the highest 
concentration tested (50 M) evoked an increase in the levels of GSH in Caco-2 cells (Figure 3E), 
whereas in SW480 cells ECG provoked a dose-dependant reduction of the intracellular GSH 
content (Figure 3F). Thus, these results show that ECG evokes a distinct reaction on GSH levels 
depending on the colon cancer cell line. 
 
Effect of ECG on the activity of antioxidant/detoxification enzymes in SW480 cells. 
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To continue the study of the potential anticarcinogenic effect of ECG, the cellular antioxidant 
enzyme system, which is essential for maintaining the adequate cellular redox status (Masella et 
al., 2005; Moon et al., 2006), was evaluated by analyzing the activity of different 
antioxidant/detoxifying enzymes (GPx, GR and GST). As shown in Figure 4, ECG evoked no 
changes in activity of GR and GST (Figures 4B and 4C), whereas treatment with 20-50 µM ECG 
induced an increase in GPx activity (Figure 4A). This effect on GPx could be related to the 
decreased GSH content exhibited by this flavanol in SW480 cells. 
 
Effect of ECG on apoptosis induction in Caco-2 and SW480 cells. 
Since redox imbalance might lead to apoptotic cell death, the enzymatic activity of caspase-3, 
which is a crucial effector in the terminal or execution phase of the apoptotic pathway, was 
examined in SW480 cells treated with ECG. As shown in Figure 5A, the presence of 30-50 M 
ECG induced the activation of caspase-3, which was coincident with the decreased cell viability, 
proliferation and intracellular GSH content. 
In addition, an imbalance in the expression of anti- and pro-apoptotic proteins is one of the major 
mechanisms underlying the ultimate fate of cells in the survival/apoptotic process (Granado-
Serrano et al., 2006). It is known that different members of the bcl-2 gene family regulate survival 
or death in mammalian cells (Granado-Serrano et al., 2006; Ramos, 2007). Thus, the possible 
modulation by ECG on the expression of anti- or proapoptotic members of this protein family 
(Bcl-x, Bad and Bax, respectively) was studied in Caco-2 and SW480 cells. ECG did not induce a 
significant effect on the levels of Bcl-xL antiapoptotic protein or proapoptotic proteins (Bax and 
Bad) in Caco-2 cells (Figures 5B and 5C). Also consistent with all the above, treatment of SW480 
cells with ECG for 24 h altered the balance among anti- and pro-apoptotic Bcl-2 family members 
(Figures 5D and 5E). 
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Bcl-xL has been proposed to be a caspase substrate, and the product of Bcl-xL cleavage, Bcl-xS, has 
a proapoptotic function. This proteolytic fragment (Bcl-xS) was detected when SW480 cells were 
incubated for 24 h with ECG, and the levels were higher at 30-50 M ECG concentrations as 
compared to control cells (Figures 5D and 5E). ECG also induced an enhancement of Bad levels 
from 20 M up to 50 M, which showed the maximum values with 40 and 50 M ECG (Figures 
5D and 5E). Additionally, Bax was not affected by ECG incubation in SW480 cells. 
 
Effect of ECG on the survival/proliferation in Caco-2 and SW480 cells. 
PI3K/AKT and ERK-MAPK play an important role in cell survival/proliferation, and can be 
modulated by polyphenols (Ramos, 2007). To investigate whether ECG treatment in Caco-2 cells 
was able to activate key proteins related to cellular survival/proliferation, PI3K/AKT and ERK-
MAPK were analyzed. Figures 6A and 6B illustrate that a 24 h treatment with ECG did not show a 
significant effect on the levels phosphorylated AKT and ERK in Caco-2 cells. Likewise, there was 
no difference in the total levels of AKT and ERK. These results, together with the lack of effect on 
cell damage and on cell proliferation reported above, suggest that 24 h of treatment with ECG has 
neither a prominent cytotoxic effect nor a proliferative/survival action in Caco-2 cells. 
Similarly, it was investigated whether ECG treatment was able to regulate key proteins of these 
intracellular signaling cascades in SW480 cells. ECG treatment induced a decrease in AKT 
phosphorylated levels and a strong activation of ERK at concentrations higher than 20 M 
(Figures 6C and 6D). The protein expression levels of total AKT and ERK were not modified by 
ECG treatment. Therefore, it could be suggested that ECG triggers apoptosis by modulating Bcl-2 
family members, i.e. enhancing the levels of pro-apoptotic proteins (Bad) and decreasing the Bcl-
xL/Bcl-xS ratio, as well as by the activation of ERK and the inhibition of AKT. 
 
Effect of PB2 on the survival/proliferation in SW480 cells. 
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In view of the proliferative effect induced by PB2 in SW480 cells, it was studied whether this 
flavanol was able to modulate the expression of anti- and pro-apoptotic Bcl-2 proteins and/or to 
activate key proteins related to cellular survival/proliferation (AKT and ERK). To this end, 
SW480 cells were exposed to PB2 for 24 h and protein specific immunoblots were then 
performed. Treatment with PB2 did not modify the levels of the anti- (Bcl-xL) and pro-apoptotic 
(Bax and Bad) proteins and induced the phosphorylation of AKT and ERK with concentrations 
higher than 10 M after 24 h of treatment (Figure 7). Likewise, there was no difference in the total 
levels of AKT and ERK. These results, together with the effect on cell damage and cell 
proliferation reported above, suggest that 24 h of treatment with PB2 has a prominent 
proliferative/survival action in SW480 cells. 
 
Effect of ECG and PB2 on the AKT and ERK modulation in Caco-2 and SW480 cells. 
To address the role of AKT/PI-3-kinase and ERK in ECG-induced apoptotic and PB2-stimulated 
survival/proliferation effects, selective inhibitors of these proteins were used and the result on cell 
viability was determined. The concentration selected for these analyses was the lowest dose that 
showed a prominent effect on the inhibition or activation of both proteins, i.e: 30 µM. LY294002 
or PD98059 alone did not have any effect on cell viability (data not shown). 
Treatment of Caco-2 cells with PD98059 followed by the addition of ECG or PB2 (30 µM) 
showed a cytotoxic effect, whereas treatment with the AKT selective inhibitor did not alter cell 
viability in Caco-2 cells incubated with ECG or PB2 (Figures 8A and 8B). On the other hand, 
treatment of SW480 cells with the selective inhibitor LY294002 followed by the addition of ECG 
markedly increased cell damage, whereas incubation with ECG in the presence of PD98059 
showed comparable values to controls (Figure 8C). In addition, in SW480 cells, the treatment with 
the selective inhibitors LY294002 or PD98059 followed by the addition of PB2 returned the cell 
viability to similar levels of those of control cells (Figure 8D). 
  17 
Taken all together, it could be suggested that cellular survival seemed to depend on the induction 
of the ERK pathway in Caco-2 cells, whereas in SW480 cells the modulation of both AKT/PI-3-
kinase and ERK signaling cascades seemed to contribute to the fate of the cells. 
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4. Discussion 
In this study, we evaluated the anticarcinogenic properties of three catechins (EC, ECG and PB2) 
with different degree of polymerization and galloylation in two human colon cancer cells with 
distinct degree of differentiation, according to their grade of infiltration or metastasis (Flatmark et 
al., 2004). These flavanols have demonstrated in different extension a potential anticarcinogenic 
effect in distinct cell lines, such as oral cavity (Babich et al., 2005, 2006), prostate (Chung et al., 
2001), hepatic (Granado-Serrano et al., 2009a), neck squamous (Lim et al., 2006) and colon (Baek 
et al., 2004; Gossé et al., 2005; Rodríguez-Ramiro et al., 2011; Tan et al., 2000; Yang et al., 1998). 
In addition, the degree of differentiation among cells from the same tissue seems to be important 
for such selective cytotoxicity (Babich et al., 2005, 2006; Yang et al., 1998). Our results revealed 
that EC, ECG and PB2 induce a differential cellular response depending on their chemical 
structure and the proliferative rate of the colon cancer cell line. 
The cytotoxic effects of the three flavanols on Caco-2 cells and of EC on SW480 cells are 
irrelevant as demonstrated by the lack of variations in cell viability and proliferation, as previously 
reported for these dietary phenolic compounds in other cell cultures prostate (Chung et al., 2001), 
oral (Babich et al., 2005), lung (Yang et al., 1998), and colon (Tan et al., 2000; Yang et al., 1998) 
cancer cells. Accordingly, EC induces cell survival through the activation of signaling pathways 
(Granado-Serrano et al., 2009a) and protects liver-derived cells from an oxidative stress by 
returning the antioxidant defense system to a steady-state activity (Granado-Serrano et al., 2009b; 
Martin et al., 2008). Interestingly, PB2 seems to slightly promote proliferation of SW480 cells. 
Similarly it has been reported that EC increased cell proliferation in colon carcinoma LoVo cells 
(Tan et al., 2000). 
ECG displayed a differential growth inhibitory effect on the two human colon cancer cell lines, 
inducing a decrease in cell proliferation in the less differentiated SW480 cells, but not in Caco-2 
cells, which are akin to colonocytes. In line with this, a different susceptibility has been described 
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for HCT116 and HT29 colon cancer cells in comparison to Caco-2 cells after their incubation with 
propolis ethanol extracts, showing a more remarkable growth decrease in HCT116 and HT29 cells 
with a high proliferation rate (Ishihara et al., 2009). Similarly, the cytotoxic effect of EC and ECG 
was more pronounced in human cancer oral cavity cells than in their normal counterparts (Babich 
et al., 2005). 
ECG differs from EC only by the presence of a gallic acid molecule on the B-ring, although ECG 
seems to be more biologically active as an antiproliferative agent than EC and procyanidins 
(Babich et al., 2005; Rodríguez-Ramiro et al., 2011; Tan et al., 2000). Thus, ECG showed a higher 
growth suppression and apoptosis induction potential than EC in prostate cancer cells (Chung et 
al., 2001). In this regard, the influence of catechin chemical structure on antiproliferative activity 
has to be considered. Research with different cell lines has shown that galloylation of catechins 
could be an important chemical characteristic (Fiuza et al., 2004; Lizarraga et al., 2008). Thus, in 
HT-29 cells treated with a procyanidin-rich grape extract, the fractions most efficient inducing 
apoptosis were those with the highest percentage of galloylation (Lizarraga et al., 2008). 
ROS are highly reactive metabolites generated during normal cell metabolism and could act as 
signaling factors. There is growing evidence that intracellular ROS may be directly related to the 
depletion of GSH. Our study shows a decrease of ROS production induced by ECG in both cell 
lines together with an induction of GSH levels by ECG in Caco-2 cells and a reduction in SW480 
cells. There is evidence showing that ECG possesses a high antioxidant activity and decreases the 
steady-state generation of ROS in Caco-2 cells without affecting cell viability or intracellular GSH 
levels (Rodríguez-Ramiro et al., 2011). All these effects have been related to the prevention or 
delay of appearance of conditions that cause oxidative stress in the cell (Azam et al., 2004; Chen et 
al., 2002; Rodríguez-Ramiro et al., 2011) and may also reflect the ability of ECG to modulate the 
cellular antioxidant defenses (Rodríguez-Ramiro et al., 2011). 
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Interestingly, ECG also reduced ROS generation in SW480 cells, but this occurs together with a 
dramatic depletion of GSH intracellular levels and a diminished cell viability and proliferation. In 
this regard, other studies have reported a decreased steady-state generation of ROS induced by 
EGCG and ECG, which has been related to a suppression of ONOO− formation and/or modulation 
of nitrite levels by both catechins due to their high antioxidant capacity (Coyle et al., 2008). 
Moreover, it should be highlighted that the loss of cellular GSH redox status seems to be an 
important player in apoptotic signaling (Granado-Serrano et al., 2009b; Rodríguez-Ramiro et al., 
2010). 
Flavanols have been recently shown to provide a parallel protection by enhancing the activity of a 
number of protective GSH-dependent enzymes (Granado-Serrano et al., 2009b; Martin et al., 
2010; Masella et al., 2005; Moon et al., 2006), which seem to play an essential role in cancer 
prevention (Moon et al., 2006). In line with this potential mechanism of action, it has been shown 
that in Caco-2 cells PB2 increases the activity of antioxidant/detoxification enzymes, ECG 
increases the activity of GPx and EC does not affect to any activity of the protective GSH-
dependent enzymes (Rodríguez-Ramiro et al., 2010, 2011). In the present study ECG evokes a 
substantial increase in GPx activity without altering GR and GST activities in SW480 cells. This 
outcome indicates that ECG-treated SW480 cells are under oxidative stress conditions (Alia et al., 
2005), which could also be connected with the depletion of GSH levels and cell death. 
ECG-induced apoptosis has already been demonstrated in colon (Baek et al., 2004; Tan et al., 
2000; Yang et al., 1998) and in lung (Yang et al., 1998) cancer cells. ECG also induced caspase-3 
activity, and DNA fragmentation, indicative of apoptosis in human oral cancer cells (Babich et al., 
2005). However, the modes of action underlying these effects have not been clearly defined. 
As our results showed, expression of Bcl-xL, Bcl-xS, Bad and Bax could be differently regulated 
by ECG suggesting that the balance in the expression of these proteins might be involved in the 
control of the apoptotic process (Granado-Serrano et al., 2006, 2007). ECG decreased the Bcl-
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xL/Bcl-xS ratio in SW480 cells; thus, regulation of Bcl-xL protein levels seems to be, at least in 
part, caspase-dependent in SW480 cells, which agrees with previous results in hepatic cells treated 
with quercetin (Granado-Serrano et al., 2006). 
On the contrary, in Caco-2 cells the expression levels of Bax and Bad (proapoptotic), as well as 
Bcl-xL (antiapoptotic) remained unchanged after treatment with ECG; moreover, the proapoptotic 
Bcl-xS resulting from Bcl-x cleavage as an indication of apoptotic cell death was not detected. 
Similarly, unchanged levels of Bcl-2, Bcl-xL, and Bax have been described in a study carried out 
with EGCG in prostatic cancer cells (Chung et al., 2001). These results suggest that Bcl-2 proteins 
might not be directly involved in the molecular signaling pathways activated by ECG in Caco-2 
cells. 
AKT promotes cell survival by inhibiting apoptosis, and its phosphorylation has been considered a 
critical factor in the progression of CRC (Pan et al., 2011). Similarly, ERK is also required for 
survival (Nicholson and Anderson, 2002), but diverse studies have suggested that the role of ERK 
in determining the fate of cells (survival or death) is cell type specific (Zhou et al., 2005). ECG 
induced an enhancement of p-ERK and a diminution of p-AKT levels in SW480 cells, whereas it 
did not alter the levels of p-AKT or p-ERK in Caco-2 cells. In this regard, it has been reported that 
catechins differently affect ERK activation in HT-29 cells (Jung et al., 2011). Thus, ECG, as well 
as EC and EGC, did not affect p-ERK levels at a concentration of 30 M in HT-29 cells (Jung et 
al., 2011). Similarly, other natural compounds enhanced p-ERK levels and decreased p-AKT 
values leading to apoptosis in diverse colon cancer cells (Auyeung et al., 2010; Hyun et al., 2009). 
In line with this, the blockage of ERK by a pharmacological inhibitor in SW40 cells treated with 
ECG led to the recovery of cell viability, whereas the decline of AKT by a specific inhibitor 
provoked an increase in the number of dead cells. 
PB2 increased proliferation as well as p-AKT and p-ERK levels in SW480 cells. This proliferative 
effect could be related to the activation of key proteins in survival/proliferation pathways, since 
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the selective blockage of the PI-3-kinase and ERK pathways by pharmacological inhibitors 
suppressed PB2-induced proliferation in SW480 cells, as previously shown for EC (Granado-
Serrano et al., 2007). In line with this, it has been recently demonstrated that PB2 exerted a 
protective role against an induced oxidative stress in Caco-2 cells (Rodríguez-Ramiro et al., 2010, 
2011). In addition, cellular survival seemed to depend on the induction of the ERK pathway in 
Caco-2 cells, since incubation with the inhibitor PD98059 in the presence of PB2 reduced the 
number of viable cells, which was not affected after the blockage of the AKT/PI3K pathway. 
However, it should be highlighted that apoptosis induction by highly oligomeric procyanidins has 
been described (degree of polymerization 4 or superior) (Gossé et al., 2005). 
Although serum bioavailability of flavanols is low, daily intakes as high as 18-50 mg/day have 
been reported (Manach et al., 2005), and steady-state concentrations up to 35 μM of EC have been 
observed in rat serum 1 h after oral administration of the flavanol (Baba et al., 2001). In addition, 
previous work (Aura et al., 2005) suggested that a major portion of ingested polyphenols survive 
digestion in the upper gastrointestinal tract (GIT) and reach the colon, where they could be 
subjected to fermentation by colonic microflora. This has been confirmed in human ileostomy 
patients (Karle et al., 2006). Thus, considering the high catechin content of green tea and cocoa, 
colonic cells could be exposed to flavanols levels similar to those tested in the present study. 
Therefore, our studies show for the first time that ECG at a physiological relevant dosage inhibited 
the growth and induced apoptosis in colon SW480 cells, but not in Caco-2 cells. On the contrary, 
PB2 promoted cell growth of SW480 cells by activating survival/proliferation pathways. However, 
before proposing a flavanol for therapeutic use further studies are needed (probing the lack of 
toxicity on the primary healthy colon cells, etc.). 
In summary, EC, ECG and PB2 exert a different response depending on their distinct chemical 
structure and the different degree of cell differentiation: ranging from no effect of any of the tested 
flavanols on Caco-2 cells to a proapoptotic effect of ECG in SW480 cells (feasibility interpreted as 
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a chemopreventive action), to a survival/proliferative effect of PB2 on this cell line, which is an 
undesirable effect in cancer chemoprevention. Thus, these results highlight the importance of a 
holistic approach to the study of the biological effects of phytochemicals and call for caution on 
the conclusions derived from their studies. 
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Figure captions 
 
Figure 1. Effect of flavanols on cell viability in (A) Caco-2 cells and (B) SW480 cells after 24 h 
of incubation. Values expressed as percent of control are means ± SD of 4 independent 
experiments with 2-3 separate samples each (n= 8-10). For each isolated flavanol in each plot, bars 
with the same letter denote similar results; meanwhile, bars with different letters indicate data that 
are statistically different (P<0.05). 
 
Figure 2. Effect of flavanols on cell proliferation in (A) Caco-2 cells and (B) SW480 cells after 24 
h of incubation. Cell proliferation was calculated as percentage of the relative increase of BrdU 
incorporated into genomic DNA over the control values. Data represent means ± SD of 3 
independent experiments with 3-4 separate samples each (n= 10-12). For each isolated flavanol in 
each plot, bars with the same letter denote similar results; meanwhile, bars with different letters 
indicate data that are statistically different (P<0.05). 
 
Figure 3. Effect of ECG on LDH leakage, intracellular ROS generation and GSH concentration in 
(A, C and E) Caco-2 cells and (B, D and F) SW480 cells. LDH leakage, ROS production and GSH 
concentration were determined in cells treated with the noted concentrations of ECG during 24 h. 
LDH leakage is expressed as percent of LDH activity in the culture medium of the total activity, 
culture medium plus intracellular. ROS production is expressed as arbitrary fluorescence units. 
GSH values are expressed as percent of control values. Data are means ± SD of 4 independent 
experiments with 2-3 separate samples each (n= 6-8). For each plot, bars with the same letter 
denote similar results; meanwhile, bars with different letters indicate data that are statistically 
different (P<0.05). 
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Figure 4. Effect of ECG on the activity of antioxidant/detoxification enzymes in SW480 cells 
after 24 h treatment with 10-50 μM ECG for 24 h. (A) GPx, (B) GR and (C) GST activities were 
measured as described in Materials and Methods. Values expressed as percent of control are 
means ± SD of 3 independent experiments with 2-3 separate samples each (n= 6-8). For each 
analyzed enzymatic activity, bars with the same letter denote similar results; meanwhile, bars with 
different letters indicate data that are statistically different (P<0.05). 
 
Figure 5. Effects of ECG on caspase-3 activity in SW480 cells, levels of Bax, Bad and Bcl-xL in 
Caco-2 cells, and Bax, Bad and Bcl-xL/Bcl-xS ratio in SW480 cells. (A) Caspase-3 activity 
(Units/mg protein). (B and D) Bands of representative experiments. (C and E) Densitometric 
quantification of Bax, Bad and Bcl-xL levels and Bcl-xL/Bcl-xS ratio. Values are expressed as a 
percentage relative to the control condition and are means ± SD of 3 independent experiments with 
2-3 separate samples each (n= 7-9) for caspase-3 activity assay and with 1-2 separate samples each 
(n = 5-6) for Western blots. For each analyzed parameter, bars with the same letter denote similar 
results; meanwhile, bars with different letters indicate data that are statistically different (P<0.05). 
 
Figure 6. Effects of ECG on levels of phosphorylated and total AKT, phosphorylated and total 
ERK in Caco-2 and SW480 cells. (A and C) Bands of representative experiments. (B and D) 
Percentage data of p-AKT/AKT and p-ERK/ERK ratios relative to controls. Values are expressed 
as a percentage relative to the control condition and are means ± SD of 3 independent experiments 
with 1-2 separate samples each (n = 5-6). For each analyzed parameter, bars with the same letter 
denote similar results; meanwhile, bars with different letters indicate data that are statistically 
different (P<0.05). 
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Figure 7. Effects of PB2 on the levels of Bax, Bad and Bcl-xL, phosphorylated and total AKT, 
phosphorylated and total ERK in SW480 cells. (A) Bands of representative experiments. (B) 
Densitometric quantification of Bax, Bad and Bcl-xL levels. (C) Bands of representative 
experiments. (D) Percentage data of p-AKT/AKT and p-ERK/ERK ratios relative to controls. 
Values are means ± SD of 3 independent experiments with 1-2 separate samples each (n = 4-6). 
For each analyzed parameter, bars with the same letter denote similar results; meanwhile, bars 
with different letters indicate data that are statistically different (P<0.05). 
 
Figure 8. Effect of ECG and PB2 and selective inhibitors LY294002 (LY) and PD98059 (PD) on 
cell viability in (A and B) Caco-2 cells and (C and D) SW480 cells after 24 h of incubation. Cells 
were incubated with or without 30 M ECG or PB2 for 24 h in the presence or absence of 50 M 
PD or 25 M LY. Cell viability was determined by crystal violet and expressed as relative 
percentage of control cells staining. Data represent means ± SD of 3 independent experiments with 
3-4 separate samples each (n=8-10). For each plot, bars with the same letter denote similar results; 
meanwhile, bars with different letters indicate data that are statistically different (P<0.05). 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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Figure 6. 
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Figure 7. 
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Figure 8. 
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